Ketoconazole as a secondary hormonal intervention in advanced prostate cancer.
Liebertz
Christine
C
Memorial Sloan-Kettering Cancer Center, New York, NY, USA. liebertc@mskcc.org
Fox
Patricia
P
D018674:Adrenergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007654:Ketoconazole / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000451:nursing
D018674:Adrenergic Antagonists; D018931:Antineoplastic Agents, Hormonal; D007654:Ketoconazole